These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20648027)

  • 1. Biostatistics and pharmacometrics: quantitative sciences to propel drug development forward.
    Smith BP; Vincent J
    Clin Pharmacol Ther; 2010 Aug; 88(2):141-4. PubMed ID: 20648027
    [No Abstract]   [Full Text] [Related]  

  • 2. ASCPT Task Force for advancing pharmacometrics and integration into drug development.
    Goldberger MJ; Singh N; Allerheiligen S; Gobburu JV; Lalonde R; Smith B; Ryder S; Yozviak A
    Clin Pharmacol Ther; 2010 Aug; 88(2):158-61. PubMed ID: 20648032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences with learning and confirming in drug and biological development.
    Patterson SD
    Clin Pharmacol Ther; 2010 Aug; 88(2):161-3. PubMed ID: 20648033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacometrics and the transition to model-based development.
    Grasela TH; Dement CW; Kolterman OG; Fineman MS; Grasela DM; Honig P; Antal EJ; Bjornsson TD; Loh E
    Clin Pharmacol Ther; 2007 Aug; 82(2):137-42. PubMed ID: 17632539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving productivity with model-based drug development: an enterprise perspective.
    Grasela TH; Slusser R
    Clin Pharmacol Ther; 2010 Aug; 88(2):263-8. PubMed ID: 20592720
    [No Abstract]   [Full Text] [Related]  

  • 6. Next-generation model-based drug discovery and development: quantitative and systems pharmacology.
    Allerheiligen SR
    Clin Pharmacol Ther; 2010 Jul; 88(1):135-7. PubMed ID: 20531467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical guide for clinical pharmacology & therapeutics.
    Clin Pharmacol Ther; 2010 Aug; 88(2):150-2. PubMed ID: 20592719
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trial simulation: a review.
    Holford N; Ma SC; Ploeger BA
    Clin Pharmacol Ther; 2010 Aug; 88(2):166-82. PubMed ID: 20613720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of biostatistics and pharmacometrics computing platforms for efficient and reproducible PK/PD analysis: a case study.
    Ou YC; Lo A; Lee B; Liu P; Kimura K; Eary C; Hopkins A
    J Clin Pharmacol; 2013 Nov; 53(11):1112-20. PubMed ID: 23913679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to simultaneous analysis of frequency and severity of symptoms.
    Plan EL; Karlsson KE; Karlsson MO
    Clin Pharmacol Ther; 2010 Aug; 88(2):255-9. PubMed ID: 20613722
    [No Abstract]   [Full Text] [Related]  

  • 11. Practical and statistical considerations on simultaneous global drug development.
    Li N; Wang W
    J Biopharm Stat; 2012 Sep; 22(5):1074-7. PubMed ID: 22946951
    [No Abstract]   [Full Text] [Related]  

  • 12. Time for quantitative clinical pharmacology: a proposal for a pharmacometrics curriculum.
    Holford N; Karlsson MO
    Clin Pharmacol Ther; 2007 Jul; 82(1):103-5. PubMed ID: 17495873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacometrics and Systems Pharmacology 2030.
    Mentré F; Friberg LE; Duffull S; French J; Lauffenburger DA; Li L; Mager DE; Sinha V; Sobie E; Zhao P
    Clin Pharmacol Ther; 2020 Jan; 107(1):76-78. PubMed ID: 31758700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R and nlmixr as a gateway between statistics and pharmacometrics.
    Fidler M; Hooijmaijers R; Schoemaker R; Wilkins JJ; Xiong Y; Wang W
    CPT Pharmacometrics Syst Pharmacol; 2021 Apr; 10(4):283-285. PubMed ID: 33951757
    [No Abstract]   [Full Text] [Related]  

  • 15. Current research in biostatistics.
    Afifi AA; Yu F
    Am J Ophthalmol; 2010 Mar; 149(3):364-6. PubMed ID: 20172063
    [No Abstract]   [Full Text] [Related]  

  • 16. The clinical pharmacist in drug research and development. Pharmacoepidemiology.
    Stewart RB
    Drug Intell Clin Pharm; 1987 Jan; 21(1 Pt 2):121-4. PubMed ID: 3816571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical Properties of the Design for Simultaneous Global Drug Development Program.
    Liu K; Yuan Z; Chen G; Huang Q; Wenrich J
    J Biopharm Stat; 2015; 25(6):1135-44. PubMed ID: 25321600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biostatistics and clinical epidemiology. 1. The introductory concepts].
    Klersy C
    G Ital Cardiol; 1995 Jan; 25(1):117-24. PubMed ID: 7642008
    [No Abstract]   [Full Text] [Related]  

  • 19. How many, powerfully?
    Bangdiwala SI
    Int J Inj Contr Saf Promot; 2011 Dec; 18(4):337-40. PubMed ID: 22142386
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiscale modeling in drug discovery and development: future opportunities and present challenges.
    Vicini P
    Clin Pharmacol Ther; 2010 Jul; 88(1):126-9. PubMed ID: 20520608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.